The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUSTM (MM-010): a phase 3b study in refractory multiple myeloma.

Dimopoulos MA, Palumbo A, Corradini P, Cavo M, Delforge M, Di Raimondo F, Weisel KC, Oriol A, Hansson M, Vacca A, Blanchard MJ, Goldschmidt H, Doyen C, Kaiser M, Petrini M, Anttila P, Cafro AM, Raymakers R, San Miguel J, de Arriba F, Knop S, Röllig C, Ocio EM, Morgan G, Miller N, Simcock M, Peluso T, Herring J, Sternas L, Zaki M, Moreau P. Blood. 2016 May 25. pii: blood-2016-02-700872. [Epub ahead of print] READ MORE

Posted: June 23, 2016

The influence of baseline characteristics and disease stage on health-related quality of life in multiple myeloma: findings from six randomized controlled trials.

Robinson D Jr, Esseltine DL, Regnault A, Meunier J, Liu K, van de Velde H. Br J Haematol. 2016 Jun 5. doi: 10.1111/bjh.14058. [Epub ahead of print] READ MORE

Posted: June 23, 2016

Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials.

Siegel DS, Weisel KC, Dimopoulos MA, Baz R, Richardson P, Delforge M, Song KW, San Miguel JF, Moreau P, Goldschmidt H, Cavo M, Jagannath S, Yu X, Hong K, Sternas L, Zaki M, Palumbo A. Leuk Lymphoma. 2016 Jun 7:1-6. [Epub ahead of print] READ MORE

Posted: June 23, 2016

Page 20 of 87« First...10...1819202122...304050...Last »